Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 11.367.139 | 504.464 | 2 | ||
2010 | 0 | 26.570.057 | 3.578.816 | 4 |
Total number of partners: 2218
Partner loyalty:
Frequent Partner: (> 2 projects): 917
Rare Partner: 1301
Frequent / Rare Partner Ratio: 0.7
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-01-01 | Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment | IMPACTT | participant | 5.376.180 | 10 |
2011-01-01 | Treatment of reperfusion injury using a mitochondrial targeted approach: towards a better understanding of the disease | MITOCARE | participant | 5.990.959 | 17 |
2010-10-01 | Clinical development of Enzyme Replacement Therapy in alpha-Mannosidosis patients using recombinant human enzyme | ALPHA-MAN | participant | 5.887.150 | 12 |
2010-03-01 | Vitamin D And LIfestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention | DALI | participant | 2.999.429 | 16 |
2010-01-01 | Fatty liver: Inhibition of Progression | FLIP | participant | 5.983.478 | 17 |
2010-01-01 | Beta Cell Therapy in Diabetes | BETACELLTHERAPY | participant | 11.700.000 | 18 |